---
schema_version: "secwatch.filing_event.v1"
accession: "0000019584-25-000004"
form_type: "8-K"
ticker: "CHE"
cik: "0000019584"
company_name: "CHEMED CORP"
filed_at: "2025-10-28T23:59:59+00:00"
generated_at: "2026-05-17T02:00:40.747016+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Chemed Q3 GAAP EPS falls 10.8% to $4.46; adjusted EPS down 6.6% to $5.27

## Summary
- Consolidated revenue $624.9M (+3.1% YoY); VITAS revenue $407.7M (+4.2%), Roto-Rooter $217.2M (+1.1%).
- VITAS ADC 22,327 (+2.5%); admissions up 5.6%; Medicare Cap accrual $6.1M vs $2.2M prior year.
- Roto-Rooter adjusted EBITDA $49.4M (-12.4%); margin 22.7% vs 26.2% prior year.
- Chemed: $129.8M cash, no debt; repurchased 407,500 shares for $180.8M during quarter.
- Reiterates FY2025 adjusted EPS guidance $22.00-$22.30, assuming no Florida Medicare Cap.

## SEC filing metadata
- accession: 0000019584-25-000004
- form_type: 8-K
- ticker: CHE
- cik: 0000019584
- company_name: CHEMED CORP
- filed_at: 2025-10-28T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/19584/000001958425000004/0000019584-25-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/19584/000001958425000004/che-20251028x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000019584-25-000004
- JSON: https://secwatch.observer/filing/0000019584-25-000004.json
- Plain text: https://secwatch.observer/filing/0000019584-25-000004.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.